Alliance Global Partners lowered the firm’s price target on Cresco Labs (CRLBF) to C$3.25 from C$3.50 and keeps a Buy rating on the shares following the Q4 report. The company’s initiatives set the stage for a return to growth in the years ahead, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRLBF:
